Spirulina Prevents Atherosclerosis by Reducing Hypercholesterolemia in Rabbits Fed a High-Cholesterol Diet

1) Steinberg D. 2002. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 8: 1211-1217.

10.1016/0002-8703(93)90102-F

3) Catapano AL, Maggi FM, Tragni E. 2000. Low density lipoprotein oxidation, antioxidants, and atherosclerosis. Curr Opin Cardiol 5: 355-363.

4) Mashima R, Witting PK, Stocher R. 2001. Oxidants and antioxidants in atherosclerosis. Curr Opin Lipidol 12: 411-418.

5) Belay A, Ota Y, Miyakawa K, Shimamatsu H. 1993. Current knowledge on potential health benefits of spirulina. J Appl Phycol 5: 235-241.

10.2174/138920105774370607

NAGAOKA SATOSHI, 2005, 135, 2425, 10.1093/jn/135.10.2425

10.1021/jf070529g

IWATA K, 1990, 36, 165, 10.3177/jnsv.36.165

1990, 31, 859, 10.1016/S0022-2275(20)42785-3

11) Poole JCF, Florey HW. 1958. Changes in the endothelium of the aorta and the behavior of macrophages in experimental atheroma in rabbits. J Pathol Bacteriol 75: 245-250.

12) Imai H, Lee KT, Pastori S, Panlilio E, Florentin R, Thomas WA. 1966. Atherosclerosis in rabbits. Architectural and subcellular alteration of smooth muscle cells of aortas in response to hyperlipidemia. Exp Mol Pathol 5: 273-310.

13) Nam KH, Choi JH, Seo YJ, Lee YM, Won YS, Lee MR, Lee MN, Park JG, Kim YM, Kim HC, Lee CH, Lee HK, Oh SR, Oh GT. 2006. Inhibitory effects of tilianin on the expression of inducible nitric oxide synthase in low density lipoprotein receptor deficiency mice. Exp Mol Med 38: 445-452.

14) Lee JH, Oh GT, Park SY, Choi JH, Park JG, Kim CD, Lee WS, Rhim BY, Shin YW, Hong KW. 2005. Cilostazol reduces atherosclerosis by inhibition of superoxide and tumor necrosis factor-α formation in low-density lipoprotein receptor-null mice fed high cholesterol. J Parmacol Exp Ther 313: 502-509.

1994, 35, 2114, 10.1016/S0022-2275(20)39918-1

1996, 126, 564, 10.1093/jn/126.2.564

17) Kolodgie FD, Katocs AS Jr, Largis EE, Wrenn SM, Cornhill JF, Herderick EE, Lee SJ, Virmani R. 1996. Hypercholesterolemia in the rabbit induced by feeding graded amounts of low-level cholesterol. Methodological considerations regarding individual variability in response to dietary cholesterol and development of lesion type. Arterioscler Thromb Vasc Biol 16: 1454-1464.

18) Adams MR, Kaplan JR, Manuck SB, Koritnik DR, Parks JS, Wolfe MS, Clarkson TB. 1990. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys lack of an effect of added progesterone. Arteriosclerosis 10: 1051-1057.

19) Narayanaswamy M, Wright KC, Kandarpa K. 2000. Animal models for atherosclerosis, restenosis, and endovascular graft research. J Vasc Interv Radiol 11: 5-17.

20) National Institutes of Health, National Research Council. 1996. Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, DC.

21) Kim SJ, Bok SH, Lee SK, Kim HJ, Lee MK, Park YB, Choi MS. 2005. Anticholesterolemic effects of 3,4-di(OH)-phenyl-propionic amides in high-cholesterol fed rats. Toxicol Appl Pharmacol 208: 29-36.

10.1172/JCI113652

23) Kobayashi H, Matsushita M, Oda K, Nishikimi N, Sakurai T, Komori K. 2004. Effect of atherosclerotic plaque on the enlargement of an experimental model of abdominal aortic aneurysm in rabbits. Eur J Vasc Endovasc Surg 28: 71-78.

24) Ross R. 1993. The pathogenesis of atherosclerosis: a prospective of the 1990s. Nature 6423: 801-809.

25) Tsao PS, Cooke JP. 1998. Endothelial alteration in hypercholesterolemia: more than simply vasodilator dysfunction. J Cardiovasc Pharmacol 32: 548-553.

26) Yagi K. 1988. Lipid peroxide level in the senescence-accelerated mouse. J Lin Biochem Nutr 5: 21-27.

10.1021/bi00705a004

28) MacKinnon AM, Savage J, Gibson RA, Barter PJ. 1985. Secretion of cholesteryl ester-enriched very low density lipoproteins by the liver of cholesterol-fed rabbits. Atherosclerosis 54: 145-155.

29) Yanni AE. 2004. The laboratory rabbit: an animal model of atherosclerosis research. Lab Anim 38: 246-256.

30) Torres-Duran PV, Ferreira-Hermosillo A, Juarez-Oropeza MA. 2007. Antihyperlipidemic and antihypertensive effects of <i>Spirulina maxima</i> in an open sample of Mexican population: a preliminary report. Lipids Health Dis 6: 33-40.

SUGIYAMA K, 1986, 32, 413, 10.3177/jnsv.32.413

DVIR I, 2000, 84, 469, 10.1017/S000711450000177X

33) Palmer GH, Dixon DG. 1996. Effect of pectin dose on serum cholesterol levels. Am J Clin Nutr 18: 437-442.

34) Henrikson R. 1989. Earth Food Spirulina, p 27-65. Recolina Ltd, Ronore Enterprises Inc, Launa Beach, CA.

35) Mazo VK, Gmoshinskii IV, Zilova IS. 2004. Microalgae Spirulina in human nutrition. Vopr Pitan 73: 45-53.

36) Bhat VB, Madyastha KM. 2001. Scavenging of peroxynitrite by phycocyanin and phycocyanobilin from<i> Spirulina platensis</i>: protection against oxidative damage to DNA. Biochem Biophys Res Commun 286: 262-266.

10.1006/bbrc.2000.3725

38) Mascher D, Paredes-Carbajal MC, Torres-Dur&aacute;n PV, Zamora-Gonz&aacute;lez J, D&iacute;az-Zagoya JC, Ju&aacute;rez-Oropeza MA. 2006. Ethanolic extract of <i>Spirulina maxima</i> alters the vasomotor reactivity of aortic rings from obese rats. Arch Med Res 37: 50-57.